# E3 Structure and Content of Clinical Study Reports - Questions and Answers (R1) - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/e3-structure-and-content-of-clinical-study-reports-questions-and-answers-r1/5b7e3d17-9b0a-44df-bfcf-df3fae8991ae

> FDA guidance document: E3 Structure and Content of Clinical Study Reports - Questions and Answers (R1). Issue date: January 29, 2013. Get complete insights and analysis.

---

## Details

- Title: E3 Structure and Content of Clinical Study Reports - Questions and Answers (R1)
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2013-01-29
- Last Changed: 2020-04-29

## Related Documents

- [S6 (R1) Addendum: Preclinical Safety Evaluation of Biotechnology - Derived Pharmaceuticals](https://www.globalkeysolutions.net/guidances/guidance-document/s6-r1-addendum-preclinical-safety-evaluation-of-biotechnology-derived-pharmaceuticals/c9774033-823e-4e54-8323-928303b9f87d)
- [Q11 Development and Manufacture of Drug Substances](https://www.globalkeysolutions.net/guidances/guidance-document/q11-development-and-manufacture-of-drug-substances/8d1aacb1-7da4-42f7-9a3a-18b2fc871411)
- [Q8, Q9, and Q10 Questions and Answers](https://www.globalkeysolutions.net/guidances/guidance-document/q8-q9-and-q10-questions-and-answers/143dddaa-3858-4f11-a750-8ff7806e5dcd)